Clinical Trial Update: A Trial for Systemic Light-chain (AL) Amyloidosis [Phase 3]

View source ↗

Summary

A Phase 3 trial for systemic light-chain (AL) amyloidosis has completed, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: AL Amyloidosis | Phase 3 | Status: COMPLETED